Aviso: Este sitio agrega datos públicos oficiales de la FDA, ClinicalTrials.gov, PubMed y SEC EDGAR solo como referencia general. No constituye asesoramiento médico, diagnóstico, recomendaciones de tratamiento ni asesoramiento de inversión.

PubMed

Industry ties and evidence in public comments on the FDA framework for modifications to artificial intelligence/machine learning-based medical devices: a cross sectional study.

PMID: 33055121 ·

J, a, m, e, s, , A, n, d, r, e, w, , S, m, i, t, h, ;, , R, o, x, a, n, n, a, , E, , A, b, h, a, r, i, ;, , Z, a, i, n, , H, u, s, s, a, i, n, ;, , C, a, r, l, , H, e, n, e, g, h, a, n, ;, , G, a, r, y, , S, , C, o, l, l, i, n, s, ;, , A, n, d, r, e, w, , J, , C, a, r, r

RevistaBMJ open
Año
PMID33055121

Resumen

To determine the extent and disclosure of financial ties to industry and use of scientific evidence in comments on a US Food and Drug Administration (FDA) regulatory framework for modifications to artificial intelligence/machine learning (AI/ML)-based software as a medical device (SaMD). Cross-sectional study. We searched all publicly available comments on the FDA 'Proposed Regulatory Framework for Modifications to Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Devi

Fuente oficial

Ver en PubMed →

Datos obtenidos de PubMed / NCBI. Para consultar el texto completo y la información más reciente, remítase siempre al registro oficial.

↑